|
|
||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Montreal General Hospital, McGill University, Montreal, Canada. Received , 1998; revision requested ; revision received ; accepted , 1999. Supported in part by the French Society of Radiology. Address reprint requests to P.M.B., Department of Radiology, Toronto Hospital, General Division, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4.
PURPOSE: To assess the correlation between and the interobserver agreement of contrast mediumenhanced computed tomography (CT) and nonenhanced and contrast-enhanced magnetic resonance (MR) imaging findings in patients with acute pancreatitis and to correlate these findings with outcome.
MATERIALS AND METHODS: Two blinded reviewers separately assessed contrast-enhanced CT and nonenhanced and contrast-enhanced MR images in 30 patients with acute pancreatitis and established a severity index based on the presence of peripancreatic fluid collections and pancreatic necrosis. The Spearman rank correlation coefficient and weighted
statistic were used to assess the correlation between each imaging technique and the interobserver agreement, respectively. Correlation between hospitalization days, morbidity, and severity indexes were assessed by using linear correlation.
RESULTS: A strong correlation existed for both reviewers when comparing contrast-enhanced CT with nonenhanced (r = 0.82, 0.79) or contrast-enhanced (r = 0.82, 0.79) MR cholangiopancreatography or when comparing nonenhanced and contrast-enhanced MR cholangiopancreatography (r = 0.99, 1.00). The interobserver agreement in staging was stronger with nonenhanced (
= 0.76) and contrast-enhanced (
= 0.78) MR cholangiopancreatography than with contrast-enhanced CT (
= 0.70). There was no linear correlation between the severity index for contrast-enhanced CT and outcome, while there was a linear correlation between nonenhanced or contrast-enhanced MR cholangiopancreatographic staging and the patient morbidity rate.
CONCLUSION: MR cholangiopancreatography could be an alternative to contrast-enhanced CT for the initial staging of acute pancreatitis.
Index terms: Pancreas, CT, 770.12113, 770.12115 Pancreas, MR, 770.121411, 770.121412, 770.121415, 770.12143 Pancreas, necrosis, 770.291 Pancreatitis, 770.291, 770.3123, 770.45, 770.64
This article has been cited by other articles:
![]() |
V. A. Sahni and K. J. Mortele The Bloody Pancreas: MDCT and MRI Features of Hypervascular and Hemorrhagic Pancreatic Conditions Am. J. Roentgenol., April 1, 2009; 192(4): 923 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Miller, A. L. Keppke, K. Dalal, J. N. Ly, V.-A. Kamler, and G. T. Sica MRI of Pancreatitis and Its Complications: Part 1, Acute Pancreatitis Am. J. Roentgenol., December 1, 2004; 183(6): 1637 - 1644. [Full Text] [PDF] |
||||
![]() |
K. J. Mortele, W. Wiesner, L. Intriere, S. Shankar, K. H. Zou, B. N. Kalantari, A. Perez, E. vanSonnenberg, P. R. Ros, P. A. Banks, et al. A Modified CT Severity Index for Evaluating Acute Pancreatitis: Improved Correlation with Patient Outcome Am. J. Roentgenol., November 1, 2004; 183(5): 1261 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Balthazar Acute Pancreatitis: Assessment of Severity with Clinical and CT Evaluation Radiology, June 1, 2002; 223(3): 603 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Matos, O. Cappeliez, C. Winant, E. Coppens, J. Deviere, and T. Metens MR Imaging of the Pancreas: A Pictorial Tour RadioGraphics, January 1, 2002; 22(1): e2 - e2. [Abstract] [Full Text] |
||||
![]() |
M. T. Keogan and R. R. Edelman Technologic Advances in Abdominal MR Imaging Radiology, August 1, 2001; 220(2): 310 - 320. [Abstract] [Full Text] [PDF] |
||||